MCM2 could be used as a prognostic marker for various malignancies, such as cervical carcinoma, oral squamous cell carcinoma, breast cancer, and gastric cancer (Gonzalez et al., 2003; Liu et al., 2013; Filho et al., 2014; Razavi et al., 2015). The gene discussed is MCM2; the disease is cervical carcinoma.